TCM
GRTS

Triumph Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Triumph Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-207,757
Closed -$128K – 312
2024
Q2 		$128K Buy
+207,757
New +$176K 0.05% 237
2022
Q1 		– Sell
-32,000
Closed -$412K – 261
2021
Q4 		$412K Buy
+32,000
New +$354K 0.18% 121

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Triumph Capital Management's GRTS Position: Q3 2024 in Review

Triumph Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 207,757 shares — an estimated $128K sold.

Triumph Capital Management first reported a position in GRTS in Q4 2021 and held it in 2 quarters. The position peaked at $412K in Q4 2021. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Triumph Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Triumph Capital Management sold 207,757 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $128K.
  • Triumph Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Triumph Capital Management's Gritstone bio, Inc. Common Stock position peaked at $412K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Triumph Capital Management's 13F filing for Q3 2024, filed 14 Feb 2025.